Tongling Jieya Biologic Technology Co. Ltd.
Tongling Jieya Biologic Technology Co., Ltd. engages in the research and development, production, and sales of wet wipe products in China. It offers baby, adult functional, antibacterial and disinfection, household clearing, medical care, pet cleaning wipes, wet toilet papers. The company also provides beauty care products, such as emollient water, Lotion, Cream, Essence, Membranes, clean, Body S… Read more
Market Cap & Net Worth: Tongling Jieya Biologic Technology Co. Ltd. (301108)
Tongling Jieya Biologic Technology Co. Ltd. (SHE:301108) has a market capitalization of $465.12 Million (CN¥3.41 Billion) as of March 18, 2026. Listed on the SHE stock exchange, this China-based company holds position #16498 globally and #4370 in its home market, demonstrating a -0.59% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Tongling Jieya Biologic Technology Co. Ltd.'s stock price CN¥30.32 by its total outstanding shares 112556252 (112.56 Million).
Tongling Jieya Biologic Technology Co. Ltd. Market Cap History: 2021 to 2026
Tongling Jieya Biologic Technology Co. Ltd.'s market capitalization history from 2021 to 2026. Data shows change from $880.75 Million to $465.12 Million (-19.99% CAGR).
Tongling Jieya Biologic Technology Co. Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Tongling Jieya Biologic Technology Co. Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.72x
Tongling Jieya Biologic Technology Co. Ltd.'s market cap is 0.72 times its annual revenue
0.11x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
20.29x
Tongling Jieya Biologic Technology Co. Ltd.'s market cap is 20.29 times its annual earnings
0.85x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $880.75 Million | $984.45 Million | $220.05 Million | 0.89x | 4.00x |
| 2022 | $503.69 Million | $666.56 Million | $140.97 Million | 0.76x | 3.57x |
| 2023 | $522.72 Million | $622.59 Million | $115.20 Million | 0.84x | 4.54x |
| 2024 | $395.02 Million | $547.45 Million | $19.46 Million | 0.72x | 20.29x |
Competitor Companies of 301108 by Market Capitalization
Companies near Tongling Jieya Biologic Technology Co. Ltd. in the global market cap rankings as of March 18, 2026.
Key companies related to Tongling Jieya Biologic Technology Co. Ltd. by market ranking:
- Procter & Gamble Company (NYSE:PG): Ranked #35 globally with a market cap of $351.41 Billion USD.
- Unilever PLC (PINK:UNLYF): Ranked #141 globally with a market cap of $131.81 Billion USD.
- UNILEVER PLC LS -,035 (XETRA:UNV0): Ranked #147 globally with a market cap of $126.11 Billion USD ( €122.86 Billion EUR).
- L'Oréal S.A (PINK:LRLCF): Ranked #215 globally with a market cap of $94.58 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #35 | Procter & Gamble Company | NYSE:PG | $351.41 Billion | $151.48 |
| #141 | Unilever PLC | PINK:UNLYF | $131.81 Billion | $60.96 |
| #147 | UNILEVER PLC LS -,035 | XETRA:UNV0 | $126.11 Billion | €56.81 |
| #215 | L'Oréal S.A | PINK:LRLCF | $94.58 Billion | $368.10 |
Tongling Jieya Biologic Technology Co. Ltd. Historical Marketcap From 2021 to 2026
Between 2021 and today, Tongling Jieya Biologic Technology Co. Ltd.'s market cap moved from $880.75 Million to $ 465.12 Million, with a yearly change of -19.99%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥465.12 Million | -8.84% |
| 2025 | CN¥510.22 Million | +29.17% |
| 2024 | CN¥395.02 Million | -24.43% |
| 2023 | CN¥522.72 Million | +3.78% |
| 2022 | CN¥503.69 Million | -42.81% |
| 2021 | CN¥880.75 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Tongling Jieya Biologic Technology Co. Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $465.12 Million USD |
| MoneyControl | $465.12 Million USD |
| MarketWatch | $465.12 Million USD |
| marketcap.company | $465.12 Million USD |
| Reuters | $465.12 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.